New eczema drug abrocitinib tested in everyday use
NCT ID NCT05250115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the drug abrocitinib works for adults with moderate to severe atopic dermatitis (eczema) in real-world clinics in Germany. Researchers tracked 112 participants for up to 12 months to see if their skin cleared or improved. The goal was to understand the drug's effectiveness and safety outside of controlled trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- abrocitinib
- What this could lead to
- If successful, this study could confirm that abrocitinib is a safe and effective treatment option for managing moderate to severe atopic dermatitis in everyday practice.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less reliable. The study was terminated early, which may limit the data collected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS ATOPIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"Magdeburger company for Medical studies & Services"
Magdeburg, Saxony-Anhalt, 39104, Germany
-
BAG Freitag und Knöll
Falkensee, 14612, Germany
-
Cutaneum Praxis Dr. Buck
Hamburg, 20095, Germany
-
Dermatologie Bad Kreuznach - Dr. med. Georg Mauer
Bad Kreuznach, 55543, Germany
-
Dermatologie Mölln, Praxis Dr Segert
Mölln, 23879, Germany
-
Dermatologische Gemeinschaftspraxis Dres. Quist PartG
Mainz, Rhineland-Palatinate, 55128, Germany
-
Dermatologische Praxis im Hautzentrum Johannis Dr. med. Esther Völkel
Nuremberg, 90419, Germany
-
Dermatologische Spezialpraxis Dr. med. Ralph von Kiedrowski
Selters, 56242, Germany
-
Dermatologisches Studienzentrum Hunsrück - DSH
Simmern, 55469, Germany
-
Dr. Beate Schwarz
Langenau, 89129, Germany
-
Dr. Christiane Handrick Hautarztpraxis
Berlin, 10117, Germany
-
Dres. Ziethen-Stavermann GbR
Berlin, 12353, Germany
-
Elbe Kliniken Stade - Buxtehude GmbH
Buxtehude, Lower Saxony, 21614, Germany
-
Haut- und Laserzentrum Freisung Prof. Kurzen
Freising, 85354, Germany
-
Hautarztpraxis Dorittke / Kardorff
Mönchengladbach, 41236, Germany
-
Hautarztpraxis Dr. Brinkmann, Schult & Samimi-Fard
Gladbeck, 45964, Germany
-
Hautarztpraxis Dr. Hoffmann
Witten, 58453, Germany
-
Hautarztpraxis Dr. Susanne Gißler-Walter
Mutterstadt, 67112, Germany
-
Hautarztpraxis Dr. Virgil Mihaescu
Augsburg, 86150, Germany
-
Hautarztpraxis Dr. med Michael Loth
Gernsbach, 76593, Germany
-
Hautarztpraxis Dr. med. Daniela Kasche
Buxtehude, 21614, Germany
-
Hautarztpraxis Dr. med. Matthias Lütten
Hamburg, 20095, Germany
-
Hautarztpraxis Dr. med. Thomas Schirmer
Berlin, 12489, Germany
-
Hautarztpraxis Mortazawi
Remscheid, 42897, Germany
-
Hautarztpraxis Weid
Bingen, 55411, Germany
-
Hautarztpraxis an der Hase Studienzentrum
Bramsche, 49565, Germany
-
Hautzentrum
Bergen, 18528, Germany
-
Hautzentrum Weißensee
Berlin, 13086, Germany
-
Hautärzte Braunschweig
Braunschweig, 38114, Germany
-
Hautärztliche Gemeinschaftspraxis
Ahaus, 48688, Germany
-
Kosmedikulm
Kulmbach, 95326, Germany
-
Praxis Dr. A. Magerl
Bensheim, 64625, Germany
-
Praxis Dr. Quack
München, 81539, Germany
-
Praxis Dr. Voth
Cologne, 50677, Germany
-
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
-
ZENTderma, Dr. Rolf Ostendorf
Mönchengladbach, 41061, Germany
-
dermaSANA
Karlsruhe, 76131, Germany
-
ÜUeberoertliche Gemeinschaftspraxis Jost Kai Rietkoetter Robert Jablonka
Gelsenkirchen, North Rhine-Westphalia, 32423, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-World dupixent: does it live up to the hype for eczema?
- Scientists hunt for biological clues to severe childhood eczema
- Can a drug calm severe eczema itch when the rash is mild? a new study investigates
- Eczema drug nemolizumab put to the vaccine test
- New eczema drug enters first human tests
- Eczema drug study pulled before it started